GLAUKOS Corp (GKOS) stock
GKOSNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 7/30219% above fair value
$245.72−0.31 (-0.13%)
Close on Nov 13, 2026Market cap $14.55BP/E –Yield –
Glaukos ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Glaukos's ebitda for the twelve months ending Sep 30, 2026 was -$134.38M. For fiscal 2025 it was -$161.51M. The highest annual figure on record is $8.96M in fiscal 2016.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$161.51M | – |
| FY2024 | Dec 31, 2024 | -$86.72M | – |
| FY2023 | Dec 31, 2023 | -$95.05M | – |
| FY2022 | Dec 31, 2022 | -$50.74M | – |
| FY2021 | Dec 31, 2021 | -$3.21M | – |
| FY2020 | Dec 31, 2020 | -$94.17M | – |
| FY2019 | Dec 31, 2019 | -$43.99M | – |
| FY2018 | Dec 31, 2018 | -$6.74M | -310.5% |
| FY2017 | Dec 31, 2017 | $3.20M | -64.3% |
| FY2016 | Dec 31, 2016 | $8.96M | – |
| FY2015 | Dec 31, 2015 | -$6.03M | – |
| FY2014 | Dec 31, 2014 | -$8.94M | – |
| FY2013 | Dec 31, 2013 | -$13.04M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $9.78M | – |
| Q2 FY2026 | Jun 30, 2026 | -$8.40M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.06M | – |
| Q4 FY2025 | Dec 31, 2025 | -$127.70M | – |
| Q3 FY2025 | Sep 30, 2025 | -$7.23M | – |
| Q2 FY2025 | Jun 30, 2025 | -$14.12M | – |
| Q1 FY2025 | Mar 31, 2025 | -$12.45M | – |
| Q4 FY2024 | Dec 31, 2024 | -$19.93M | – |
| Q3 FY2024 | Sep 30, 2024 | -$15.66M | – |
| Q2 FY2024 | Jun 30, 2024 | -$20.98M | – |
| Q1 FY2024 | Mar 31, 2024 | -$30.15M | -369.8% |
| Q4 FY2022 | Dec 31, 2022 | -$6.87M | -182.6% |
| Q3 FY2022 | Sep 30, 2022 | -$19.95M | -263.7% |
| Q2 FY2022 | Jun 30, 2022 | -$35.10M | – |
| Q1 FY2022 | Mar 31, 2022 | $11.17M | – |
| Q4 FY2021 | Dec 31, 2021 | $8.32M | -43.4% |
| Q3 FY2021 | Sep 30, 2021 | $12.19M | – |
| Q2 FY2021 | Jun 30, 2021 | -$13.06M | – |
| Q1 FY2021 | Mar 31, 2021 | -$10.66M | – |
| Q4 FY2020 | Dec 31, 2020 | $14.69M | – |
| Q3 FY2020 | Sep 30, 2020 | -$11.24M | – |
| Q2 FY2020 | Jun 30, 2020 | -$46.09M | – |
| Q1 FY2020 | Mar 31, 2020 | -$51.53M | – |
| Q4 FY2019 | Dec 31, 2019 | -$26.07M | -941.3% |
| Q3 FY2019 | Sep 30, 2019 | -$11.47M | – |
| Q2 FY2019 | Jun 30, 2019 | -$5.35M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.10M | – |
| Q4 FY2018 | Dec 31, 2018 | $3.10M | +49.4% |
| Q3 FY2018 | Sep 30, 2018 | -$5.24M | -331.5% |
| Q2 FY2018 | Jun 30, 2018 | -$2.55M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.05M | -256.1% |
| Q4 FY2017 | Dec 31, 2017 | $2.07M | +16.5% |
| Q3 FY2017 | Sep 30, 2017 | $2.26M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.45M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.31M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.78M | – |
See a number that looks wrong?